These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1464859)

  • 1. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor.
    Roubenoff R; Roubenoff RA; Ward LM; Holland SM; Hellmann DB
    J Rheumatol; 1992 Oct; 19(10):1505-10. PubMed ID: 1464859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor.
    Engvall IL; Elkan AC; Tengstrand B; Cederholm T; Brismar K; Hafstrom I
    Scand J Rheumatol; 2008; 37(5):321-8. PubMed ID: 18666027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.
    Metsios GS; Stavropoulos-Kalinoglou A; Douglas KM; Koutedakis Y; Nevill AM; Panoulas VF; Kita M; Kitas GD
    Rheumatology (Oxford); 2007 Dec; 46(12):1824-7. PubMed ID: 18032540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis.
    Walsmith J; Abad L; Kehayias J; Roubenoff R
    J Rheumatol; 2004 Jan; 31(1):23-9. PubMed ID: 14705214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study.
    Marcora SM; Lemmey AB; Maddison PJ
    J Rheumatol; 2005 Jun; 32(6):1031-9. PubMed ID: 15940763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
    Straub RH; Paimela L; Peltomaa R; Schölmerich J; Leirisalo-Repo M
    Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid cachexia: a clinical perspective.
    Summers GD; Deighton CM; Rennie MJ; Booth AH
    Rheumatology (Oxford); 2008 Aug; 47(8):1124-31. PubMed ID: 18448480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects.
    Gao IK; Scholz P; Boehme MW; Norden C; Lemmel EM
    Rheumatol Int; 2002 Jun; 22(2):45-51. PubMed ID: 12070674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial.
    Marcora S; Lemmey A; Maddison P
    Clin Nutr; 2005 Jun; 24(3):442-54. PubMed ID: 15896432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor necrosis factor-alpha and kidney damage in rheumatoid arthritis].
    Tsybul'ko SV; Baranov AA; Borodin AG; Korshunov NI; Kirdianov SIu
    Ter Arkh; 2001; 73(5):8-11. PubMed ID: 11517757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion.
    Rall LC; Walsmith JM; Snydman L; Reichlin S; Veldhuis JD; Kehayias JJ; Abad LW; Lundgren NT; Roubenoff R
    Arthritis Rheum; 2002 Oct; 46(10):2574-7. PubMed ID: 12384914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial.
    Lemmey AB; Marcora SM; Chester K; Wilson S; Casanova F; Maddison PJ
    Arthritis Rheum; 2009 Dec; 61(12):1726-34. PubMed ID: 19950325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokines in different histological variants of rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    J Rheumatol; 2001 Jun; 28(6):1211-7. PubMed ID: 11409111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.
    Roubenoff R; Grinspoon S; Skolnik PR; Tchetgen E; Abad L; Spiegelman D; Knox T; Gorbach S
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E138-45. PubMed ID: 12067854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC; Chung SJ; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR; Dawes PT; Nixon NB; Mattey DL
    Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
    Popa C; Netea MG; de Graaf J; van den Hoogen FH; Radstake TR; Toenhake-Dijkstra H; van Riel PL; van der Meer JW; Stalenhoef AF; Barrera P
    J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.